The Valley Desk

NCT07059091 · Interventional trial

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Overall registry status Recruiting

Phase 2

Conditions Allergies, Chronic Obstructive Pulmonary Disease (COPD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov